The Valley Desk

NCT01101581 · Interventional trial

Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL

Overall registry status Withdrawn

Phase 1 · Phase 2

Conditions Aggressive NHL, Diffuse Large B-cell Lymphoma, NHL, Non Hodgkin's Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov